SITC 2025: Resources for Immunotherapy Researchers

CRI Scientific Resources

• CRI Immunotherapy Insights + Impact Report: The report synthesizes more than 150 U.S. FDA approvals from 2011 through 2024, offering a comprehensive view of how immunotherapy has evolved from a scientific breakthrough to standard of care across dozens of cancer types.  
• Nature Reviews Drug Discovery Business Brief: Cancer cell therapies: global clinical trial trends and emerging directions (OPEN ACCESS until Nov. 12)
• Interactive Tableau Dashboard: Companion to NRDD Cancer cell therapies publication

CRI Funding Opportunities

• IGNITE Award: Supports the transition of distinguished postdoctoral researchers into independent tenure-track investigators
• STAR Award: Supports mid-career scientists pursuing high-risk, high-reward research at the leading edge of cancer immunotherapy
• All CRI Grant Programs

Review selected talks from the SITC 2025 conference, featuring CRI-affiliated scientists

Sign up for our email newsletters to learn about new funding opportunities, immunotherapy research progress and patient perspectives.